Abstract

Meeting abstracts Breast cancer has been shown to be immunogenic and can stimulate an antibody immune response. Because of this immunogenicity, identification of early breast tumor antigens could allow identification of autoantibodies for the early detection of breast cancer. In this study, the

Highlights

  • Breast cancer has been shown to be immunogenic and can stimulate an antibody immune response

  • The mammary tumors that develop in these mice are genotypically similar to human luminal breast cancer and the mammary tumor development in these mice can be evaluated longitudinally, allowing for collection of sera prior to tumor development and identification of tumor specific antibodies representing the earliest alterations in the malignant transformation of normal mammary epithelium

  • We identified 6 antigens that were present in mice prior to the development of mammary tumors (Pdhx, Otud6b, Stk39, Zpf238, Lgals8, and Vps35)

Read more

Summary

Introduction

Breast cancer has been shown to be immunogenic and can stimulate an antibody immune response. Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer Identification of early breast tumor antigens could allow identification of autoantibodies for the early detection of breast cancer.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call